The failure-to-thrive syndrome in geriatric patients is marked by social withdrawal, apathy, depression, anorexia, and cognitive impairment. For therapy to be effective, the treatment plan must target several of these areas. This case report describes one such course of treatment for a patient with multiple myeloma with failure-to-thrive who was successfully treated with modafinil and mirtazapine. By using combination pharmacotherapy, we were able to achieve immediate results in a gravely ill patient.
VerderyRB. Failure to thrive in the elderly. Clinics in Geriatric Medicine1995;11:653–659.
2.
PalmerRM. ‘Failure to Thrive’ in the elderly: Diagnosis and management. Geriatrics1990;45:47–55.
3.
BerkmanBFosterLWCampionE. Failure to thrive: Paradigm for the frail elder. Gerontologist1989;29:654–659.
4.
WallaceJISchwartzRSLaCroixAZUhlmannRFPearlmanRA. Involuntary weight loss in older outpatients: Incidence and clinical significance. Journal of the American Geriatrics Society1995;43:329–337.
5.
WallaceAEKofoedLLWeatAN. Double blind placebo controlled trial of methylphenidate in older, depressed, medically ill patients. The American Journal of Psychiatry1995;152:929–931.
6.
MasandPPickettPMurrayGB. Psychostimulants for secondary depression in medical illness. Psychosomatics1991;32:203–208.
7.
MasandOJ. Psychostimulants for depression in hospitalized cancer patients. Psychosomatics1996;37:57–62.
8.
EngberTMDennisSAJonesBEMillerMSContrerasPC. Brain regional substrates for the actions of the novel wake promoting agent modafinil in the rat: A comparison with amphetamine. Neuroscience1998;87:905–911.
9.
ScammelTEEstabrookeIVMcCarthyMTChemelliRMYanagisawaMMillerMSSaperCB. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. Journal of Neuroscience2000;20:8620–8628.
10.
MenzaMAKaufmanKRCastellanosA. Modafinil augmentation of antidepressant treatment in depression. Journal of Clinical Psychiatry2000;61:378–381
11.
FawcettJBarkinRL. Review of the results from clinical studies on the efficacy, safety, and tolerability of mirtazapine for the treatment of patients with major depression. Journal of Affective Disorders1998;51:267–285
12.
FolsteinMFFolsteinSEMcHughPR. “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research1975;12:189–198
13.
RoyallDRCordesJAPolkM. CLOX: An executive clock drawing task. Journal of Neurology, Neurosurgery, and Psychiatry1998;64:588–594
14.
RajiMABradySR. Mirtazapine for treatment of depression and comorbidities in Alzheimer Disease. Annals of Pharmacotherapy2001;35:1024–1027.
